204 related articles for article (PubMed ID: 28423551)
1. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis.
Cruz MD; Ledbetter S; Chowdhury S; Tiwari AK; Momi N; Wali RK; Bliss C; Huang C; Lichtenstein D; Bhattacharya S; Varma-Wilson A; Backman V; Roy HK
Oncotarget; 2017 Mar; 8(13):20543-20557. PubMed ID: 28423551
[TBL] [Abstract][Full Text] [Related]
2. Increased microvascular blood content is an early event in colon carcinogenesis.
Wali RK; Roy HK; Kim YL; Liu Y; Koetsier JL; Kunte DP; Goldberg MJ; Turzhitsky V; Backman V
Gut; 2005 May; 54(5):654-60. PubMed ID: 15831911
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
[TBL] [Abstract][Full Text] [Related]
4. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
[TBL] [Abstract][Full Text] [Related]
5. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
6. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
7. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
8. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
9. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
10. Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender.
Cruz MD; Wali RK; Bianchi LK; Radosevich AJ; Crawford SE; Jepeal L; Goldberg MJ; Weinstein J; Momi N; Roy P; Calderwood AH; Backman V; Roy HK
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2413-21. PubMed ID: 25155760
[TBL] [Abstract][Full Text] [Related]
11. Sustained proliferation and resistance to apoptosis after a cytotoxic insult are early alterations in rat colon carcinogenesis.
Femia AP; Salvianti F; Luceri C; Dolara P; Salvadori M; Pinzani P; Caderni G
Int J Cancer; 2012 Aug; 131(3):529-36. PubMed ID: 21976248
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis.
Williams MD; Zhang X; Belton AS; Xian L; Huso T; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
J Proteome Res; 2015 Mar; 14(3):1420-31. PubMed ID: 25643065
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling.
Scarpa M; Cardin R; Bortolami M; Kotsafti A; Scarpa MC; Pozza A; Maran G; Picciocchi M; Ruffolo C; D'Incà R; Sturniolo GC; Castagliuolo I; Castoro C; Angriman I
Eur J Cancer; 2013 Jan; 49(1):254-63. PubMed ID: 22704122
[TBL] [Abstract][Full Text] [Related]
17. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
[TBL] [Abstract][Full Text] [Related]
18. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
19. Importance of serrated polyps in colorectal carcinogenesis.
Liang JJ; Bissett I; Kalady M; Bennet A; Church JM
ANZ J Surg; 2013 May; 83(5):325-30. PubMed ID: 23078414
[TBL] [Abstract][Full Text] [Related]
20. Detailed colonoscopy for detecting early superficial carcinoma: recent developments.
Tanaka S; Haruma K; Ito M; Nagata S; Oh-e H; Hirota Y; Kunihiro M; Kitadai Y; Yosihara M; Sumii K; Kajiyama G
J Gastroenterol; 2000; 35 Suppl 12():121-5. PubMed ID: 10779231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
